EU Melanoma Drugs Market Analysis

$2,350.00$4,700.00

  • Type: Oncology area
  • Published : March 2021
  • Region: Europe
  • Country: Other
  • Report ID : 541

  • Format: PPT, PDF

EU Melanoma Therapeutics Market- Size, Futuristic Trends, Growth Opportunities, Threats and Segmentation by Cancer Type (Superficial, Nodular, Lentigo Maligna, Acral Lentiginous, and Amelanotic Melanoma), By Diagnosis (Dermatoscopy, Sentinel Lymph Node biopsy, X-rays, Blood tests, CT scan, and Ultrasound), By Treatment (Early Stage Melanoma and Advanced Stage Melanoma): Share Market Analysis (2019-2028)

Clear
SKU: 541 Categories: ,

Report Overview

The EU Melanoma Therapeutics market was valued at USD 750 million in 2019 and is expected to reach USD XX million by 2028 at a CAGR of XX% during the forecast period

Melanoma is a type of skin cancer that develops in the melanocyte cells that are responsible for producing melanin, the pigment that imparts color to the skin. It occurs when unrepaired damage to skin cells leads to their rapid multiplication, thus forming malignant tumors. The primary cause of Melanoma is prolonged exposure to ultraviolet light. If detected and treated at an early stage, the disease is almost always curable. EU shows a higher market expansion because of the treatment rates and the market infiltration of premium drugs. The market for melanoma drug therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities

Market Growth Drivers

The entry of biosimilars into the market is expected to increase during the forecast period due to the patent expiration of key branded biologics. Effective immunotherapies and technological advancements in melanoma therapeutics would fuel the market further. The government initiatives in the development of novel therapies are anticipated to increase the demand, hence drive the market. The prevalence of skin allergies, melanoma, and other skin cancers in the EU is high, which serves as an opportunity for drug companies to gain a larger share in these regions. Also, the lack of awareness and high cost are expected to act as a restrain in driving the market growth during the forecast period

 

1. EU Melanoma Drugs Market Overview………..………..………………………………..
A. Market Size
2. Market Growth Drivers……………………………………………………………………….
A. Increasing entry of biosimilars into the market
B. Growing government initiatives and technological advancements
3. Major Types of Melanoma….……………….………..…………………………..….………
A. Malignant Melanoma
B. Benign Melanoma
4. Melanoma Drugs Market Segmentation…….……………………….…………….……..
A. Cancer Type:
I. Superficial
II. Nodular
III. Lentigo Maligna
IV. Acral Lentiginous
V. Amelanotic Melanoma
B. By Diagnosis
I. Dermatoscopy
II. Sentinel Lymph Node biopsy
III. X-rays, Blood tests
IV. CT scan
V. Ultrasound
C. By Treatment
I. Early-Stage Melanoma
II. Advanced Stage Melanoma
5. Melanoma Drugs Market Share……………..…………………………..…………………
A. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………….……………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………….………………………………………..……………….
A. AstraZeneca Company Product & Services, Strategies & Financials
B. Eli-Lily Company Product & Services, Strategies & Financials
C. GlaxoSmithKline Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………..……..……….…
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Melanoma Drugs Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Cancer Type:

On the basis of cancer type, the market is segmented into Superficial, Nodular, Lentigo Maligna, Acral Lentiginous, and Amelanotic Melanoma

By Diagnosis:

Based on the diagnosis, the market is segmented into Dermatoscopy, Sentinel Lymph Node biopsy, X-rays, Blood tests, CT scan, and Ultrasound

By Treatment:

Treatments for melanoma have been segmented into treatment for Early-Stage Melanoma (Excision and Mohs surgery) and Treatment for Advanced-Stage Melanoma (Chemotherapy, Biological Therapy, Radiotherapy, Targeted Therapy, Immune Therapy, Lymphadenectomy)

Major Players

The major players in the EU Melanoma Therapeutics market are AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Roche

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

Download Free Sample Report






    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements